Dr. Luetkemeyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
995 Potrero Ave
Box 0874
San Francisco, CA 94110Phone+1 415-476-4082Fax+1 415-476-6953
Education & Training
- University of California (San Francisco)Fellowship, Infectious Disease, 2003 - 2006
- University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
- Harvard Medical SchoolClass of 1999
Certifications & Licensure
- CA State Medical License 2001 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection Start of enrollment: 2008 Apr 01
- A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C Start of enrollment: 2014 Aug 01
- Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men Start of enrollment: 2019 Nov 26
Publications & Presentations
PubMed
- 62 citationsEvaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Sett...Anne F Luetkemeyer, Cynthia Firnhaber, Michelle A. Kendall, Xingye Wu, Gerald H. Mazurek
Clinical Infectious Diseases. 2016-05-01 - 17 citationsAssociation of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital.Lelia H. Chaisson, David Duong, Adithya Cattamanchi, Marguerite Roemer, Margaret A. Handley
JAMA Internal Medicine. 2018-10-01 - 407 citationsTiming of Antiretroviral Therapy for HIV-1 Infection and TuberculosisDiane V. Havlir, Michelle A. Kendall, Prudence Ive, Johnstone Kumwenda, Susan Swindells
The New England Journal of Medicine. 2011-10-20
Press Mentions
- Antibiotic Cuts Risk of HIV, STDs After Exposure, Study SaysMay 8th, 2023
- Doxy-PEP for STIs and More: Dr. Dieffenbach’s Highlights from Day 1 of CROI 2023February 21st, 2023
- Meta-Analysis Supports COVID-19 Mortality Benefit with IL-6 InhibitorsJuly 15th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: